This study aims to establish a methamphetamine (METH)-induced behavioral sensitization model using tree shrews, as well as to measure the protein expression of the dopamine D3 receptor (D3R) and dopamine transporter (DAT).
| INTRODUC TI ON
Methamphetamine (METH), a white and odorless crystalline powder commonly known as "crystal METH," is a highly addictive synthetic psychostimulant. It is a principal amphetamine-type stimulant (ATS), the abuse of which has infiltrated mainstream culture across the Asia Pacific region. METH is characterized by its excitability of the central nervous system (CNS), strong drug dependence, high relapse rate, easy access to raw materials, simple synthesis process and low production cost, the combination of which have made METH abuse an ever-growing phenomenon. By the end of 2018 in China, 1.35 million out of 2.4 million registered drug abusers were METH abusers, posing a significant socioeconomic burden (Annual report, 2017: The situation of the drug problem in China, 2018) .
Chronic METH consumption elicits compulsive drug craving and frequent relapse as well as other pathological behaviors (Miner, Phillips, & Janowsky, 2019) . METH enters dopaminergic presynaptic terminals mediated by the dopamine transporter (DAT) to promote dopamine (DA) release into the cytosol, redistribute dopamine stores and elevate cytosolic DA abundance partly via the vesicular monoamine transporter-2 (VMAT2) (Friedman, Castaneda, & Hodge, 1998) . METH was shown to inhibit mitochondrial enzyme monoamine oxidase (MAO), abrogating the cellular metabolism of DA, resulting in behavioral deficits, memory loss, and neurotoxic effects in the CNS (Zhou et al., 2019) .
Behavioral sensitization refers to the enhancement of behavioral responses to repeated and intermittent drug exposure, including augmented autonomic activity and stereotypic behavior (Steketee & Kalivas, 2011) . Drug-induced behaviorally sensitized animal models are used routinely to define the cellular and molecular mechanisms underlying drug addiction and associated psychomotor behavioral alternations (Collins et al., 2011) , and relevant tools have been developed to this effect (Kai, Nishizawa, Tsutsui, Ueda, & Kobayashi, 2015; Mohd-Yusof et al., 2016) . Further, pharmaceutical interventions can be introduced during the development of behavioral sensitization to evaluate the therapeutic effect on behavioral sensitization and reinstatement Sun et al., 2016; Zhao et al., 2014) . The principal preclinical animal models of behavioral sensitization were rats (Mohd-Yusof et al., 2016; Song et al., 2014; Zhao et al., 2014) and mice (Kai et al., 2015; Sun et al., 2016) . Considering the significant differences in neuroanatomic structures and the functional divergence of the nervous systems of rodents and humans, however, these rodent-based models may contribute limited understandings of addictive drugs' neurotoxicity and addictive behaviors in humans.
A number of studies have shown that the tree shrew (Tupaia belangeri) has a much closer phylogenetic affinity to primates than rodents do Fan et al., 2013; Ma et al., 2013) .
Compared with rodents, the tree shrew has a more developed brain at both the neuroanatomical and the neurophysiological levels, higher homology of neuropeptidomics, similar drug target protein sequences and a higher resemblance to humans in terms of the expression profiles of genes associated with numerous neuropsychiatric disorders Fan et al., 2013; Ma et al., 2013) .
However, the tree shrew has yet to be adopted as a preclinical animal model for studying METH-induced behavioral sensitization.
The mechanism of METH addiction has been studied intensively in the field of biomedicine. The neural circuits associated with METH addiction are very complex, involving multiple brain regions (Kai et al., 2015; Xu et al., 2019) and a multitude of neurotransmitters (Jiang et al., 2018; Jing, Liu, Zhang, & Liang, 2018) and protein mediators (Lee, Kim, Kim, Lee, & Jang, 2018; Mohd-Yusof et al., 2016; Sun et al., 2016; Zhao et al., 2014) . The incentive-sensitization theory of addiction is one of the most widely accepted classical theories used to explain METH-induced behavioral sensitization. Addictive drugs, as opposed to natural rewards (e.g., food, water), act on the brain's reward system to induce the excessive attribution of incentive salience to drug-associated stimuli, producing compulsive motivation and the ingraining of drug-taking habits. METH promotes the synaptic release of DA and inhibits the DAT reuptake of DA, thereby activating DA receptors and dopaminergic signaling in the brain's reward pathway to elicit reward-motivated behavior (Sun et al., 2016; Volz, Hanson, & Fleckenstein, 2007) . Studies have shown that the D3R plays an important role in METH addiction, and it has been shown to relate closely to METH-induced hyperactivity and behavioral sensitization in animal models (Collins et al., 2011; Jiang et al., 2018; Song et al., 2014; Sun et al., 2016) . To continue these findings, the present study examines the protein expression of D3R and DAT in METHinduced behavioral sensitization in tree shrews.
In this study, tree shrews are exposed to different doses of 
| ME THODS

| Animals
Male tree shrews (120-160 g, 1-year-old) were supplied by the Center of Tree Shrew Germplasm Resources, the Institute of Medical Biology, the Chinese Academy of Medical Science and Peking Union Medical College (Kunming, China). They were housed in a standard 12 hr:12 hr light/dark cycle at a room temperature of 23 ± 2℃, with access to food and water ad libitum. All experiments were approved by the Institutional Ethics Committee of Kunming Medical University and were performed in accordance with the ethical standards described in the NIH guidelines. anti-rabbit dopamine receptor D3 (Cat #: ab42114, Abcam, 1:1,000), anti-rabbit dopamine transporter (Cat #: AB1591P, EMD Millipore, 1:1,000), anti-rabbit β-Actin (Cat #: 21,338, 1:1,000, Signalway Antibody, USA), and anti-mouse/rabbit IgG and horseradish peroxidase-linked secondary antibody (Cat #: L3012, 1:5,000, Signalway Antibody, USA).
| Drugs and antibodies
| Behavior sensitization experiment
During the development (d4-d12) and expression (d17) Forty male tree shrews were equally randomized into four experimental groups: those administered with 1, 2, and 4 mg/kg METH and a control group (given the equivalent amount of normal saline). Figure 1a , the animals were habituated in the chamber for 1 hr daily for 3 days (d1-3) before the drug treatment. In the development period of behavioral sensitization (d4-12), the animals in each group received METH or saline per the set dosage at a regular time per day and were immediately placed in the chamber for testing. The animals then experienced a 4-day withdrawal period (d13-16) without the METH or saline treatment before being administered with 0.5 mg/kg METH or equivalent amount of normal saline the next day. Changes of behavior, movement distance, average speed, and motion trajectory were recorded for 1 hr daily during the development and expression periods, and stereotypic behavior scores and weight changes were also recorded.
As shown in
F I G U R E 1 (a) Experimental protocol for METH and saline treatments. (b)
Effects of different doses of METH on stereotypic behavior scores of behavioral sensitization in tree shrews on the last day (d12) of the development period of behavioral sensitization and (c) the expression period of behavioral sensitization (d17). *p < .05, **p < .01, and ***p < .001 compared to the control group. ## p < .01 compared to METH (1 mg/kg). $ p < .05 compared to METH (2 mg/kg). Data were presented as mean ± SEM. N = 10 per group
| Stereotyped behavior scores
After watching the video recordings made during the open-field tests and referring to the GHF-Dodd scoring method (Xie, Zhou, Zhang, Chen, & Wang, 2018) , stereotypic behavior scores were made as follows (Table 1) .
| Western blot
All tree shrews were euthanized using 40 mg/kg of 1% pentobarbital sodium salt (Sigma) via intraperitoneal anesthesia 24 hr after the last behavioral test, after which the PFC, DS, and NAc were harvested from each specimen and frozen in liquid nitrogen for use in subsequent experiments. Brain tissues (20 mg) from each encephalic region were homogenized in 150 μl of protein extraction buffer (Beyotime, Shanghai, China) containing protease and phosphatase inhibitors, then centrifuged at 14,000 g for 15 min at 4℃. The supernatant was collected, and the proteins were measured using the Bradford Protein Assay kit (Beyotime). After the protein sample loading buffer was added, samples were boiled at 99℃ for 10 min.
The samples were then separated by 8% SDS-PAGE and transferred to 0.45 µm polyvinylidene difluoride (PVDF) membranes (Millipore).
The membranes were blocked in 5% nonfat dry milk (diluted in the Tris-buffered saline with 0.1% Tween 20 (TBST)) for 1 hr at room temperature, then incubated in appropriate primary antibodies (1:1,000 dilution with 5% defatted milk) overnight at 4℃. Next, the membranes were washed three times for 10 min each with TBST and incubated with the secondary antibody (1:5,000 dilution with 5% defatted milk) for 1 hr at room temperature. Finally, the membranes were detected using an enhanced chemiluminescent Plus Detection kit (Millipore, USA) and visualized using a Bio-Rad Imaging system (Bio-Rad). This experiment was repeated in triplicate, and representative Western blot images were presented.
| Data analysis
Statistical analyses were performed using SPSS 21.0 (IBM SPSS) and GraphPad Prism 7.00 (GraphPad Software). All data were represented as the mean ± SEM of 10 animals for behavioral assays and three independent biological replicates for the Western blot.
Stereotyped behavior scores, motion trajectory, and Western blot data were analyzed using a one-way analysis of variance (ANOVA) and analyzed post-hoc using LSD test. Movement distance and average speed were analyzed using a two-factor (dose x time) ANOVA with repeated measures (time) and analyzed post-hoc using LSD test. A paired T-test was used in the intragroup comparison to analyze the weight changes between d12/d17 and d4. p-values of <.05 were considered statistically significant.
| RE SULTS
| METH-augmented stereotyped behavior
During the development (d4-d12) and expression (d17) 
| METH-induced biphasic effect in locomotion
Next, METH-induced behavioral sensitization on the locomotor response of the tree shrews was examined using open-field tests. Next, the average speeds of the behaviorally sensitized animals during the development (d4-d12) and expression stage (d17) were all significantly increased compared to the control group at different METH doses (p < .001 for the 1 and 2 mg/kg groups; p = .008 for the 4 mg/kg group compared to the control group). Similar to the effect of METH on movement distance, however, METH at 4 mg/kg decreased average speed compared to the 2 mg/kg group (p < .001).
These cumulative results indicate that METH doses significantly augment the movement distances and average speeds of tree shrews during the development and expression stages of behavioral sensitization. METH at 2 mg/kg produces the most significant increases in movement distance and average speed. Tree shrews mainly exhibit stereotypic behaviors at 4 mg/kg METH.
| METH-induced weight loss in behaviorally sensitized animals
The tree shrews were weighed once a day before the drug was given;
average weights exhibited a decreasing trend in all experimental groups. As shown in Figure 2g , the tree shrews' weights decreased significantly on d12 and d17 across all groups compared to their weights before the administration of METH (p 1 mg/kg < .001 on d12; p 1 mg/kg < .001 on d17; p 2 mg/kg < .001 on d12; p 2 mg/kg < .001 on d17; p 4 mg/kg < .01 on d12; p 4 mg/kg < .01 on d17). The control group did not display such weight loss at any stage. These results suggest that METH at any examined dose causes a significant reduction in body weight.
| METH-regulated endogenous expression of D3R and DAT in behaviorally sensitized animals
Prior studies indicate that both D3R and DAT are of biological significance in the neuronal circuitry underlying METH-induced behavioral sensitization and reinstatement. In this investigation, the protein expression levels of D3R and DAT in the PFC, DS, and NAc of behaviorally sensitized tree shrews exposed to METH were examined. As shown in Figure 3a 
| D ISCUSS I ON
In this study, a METH-induced behavioral sensitization model was established using tree shrews, and the expression levels of D3R and DAT in METH-induced behavioral sensitization were examined.
The spontaneous stereotypy of all METH-treated experimental groups grew significantly with each increase in METH dosage ( Figure 1) . Though any of the three tested dosage of METH can induce profound behavioral sensitization, METH at 4 mg/kg was observed to reduce locomotor ability significantly; mainly, stereotypic behaviors manifested, suggesting that sensitization to high doses of METH can escalate to the manifestation of augmented stereotypic activities that compete with locomotion. After the first administration of METH, the motor distance and average motor speed of the tree shrews in all drug groups increased significantly compared to those in the control group (Figure 2 ). METH at 1 and 2 mg/kg increased the motor distance and speed, but changes in rigid behavior were slight. With 4 mg/kg METH, the tree shrews' motor distance and speed were inhibited, and rigid behavior was obvious.
The average body weight of the tree shrews in each experimental group showed a significant downward trend as the experiment progressed, presumably associated with augmented locomotor and stereotypic activities, resulting in enhanced energy expenditure ( Figure 2 ). This indicates that METH can induce obvious behavioral sensitization in the tree shrews, which is consistent with the results of previous animal behavior studies in terms of dosage and behavioral characteristics (Wearne, Parker, Franklin, Goodchild, & Cornish, 2017; Zhu et al., 2012) . On the other note, prior studies indicated that METH use suppresses appetite, directly disrupts the gastrointestinal system and leads to malnutrition and weight loss (Fantegrossi et al., 2008) . METH consumption has also been exploited for weight control (Bruening, Perez La Mar, & Ohrt, 2018) . It is therefore speculated that these toxic effects induced by METH may also occur in the tree shrews. These two factors could be the reasons why METH induced the loss of body weight in the tree shrews.
The present study focused on D3R (Chen, Song, Yang, Wu, & Li, 2014; Le Foll et al., 2014) , which is a DR subtype closely re- We showed that METH administration heightened locomotor responses and stereotypic behaviors in all experimental groups.
METH at 2 mg/kg, maximally promotes and inhibits the protein expression of D3R and DAT, respectively, elicits the most significant increases in movement distance and average speed and moder- (Liu et al., 2014) . This study shows for the first time that D3R may also contribute to METH-induced behavioral sensitization in tree shrews.
Studies have shown that METH can not only lead to the depletion of DA but also cause the modification of DAT structures by forming a polymer complex with it. Moreover, there is a negative correlation between the formation of DAT complexes induced by METH and DAT activity (Hadlock et al., 2009 ). The present study shows that METH can significantly reduce the DAT expression in three brain regions of tree shrews, suggesting that METH may form a complex with DAT and reduce its expression and activity in different brain regions. This is consistent with previous studies demonstrating that drug abuse with substances such as METH, amphetamine, and cocaine reduces DAT levels. METH abuse can induce the release of large amounts of DA, inhibit DA reuptake and eventually induce the release of large amounts of DA, thereby reducing the expression of DAT.
Thus, D3R and DAT may play very important roles in METHinduced behavioral sensitization in tree shrews.
| CON CLUS IONS
We established and characterized a METH-induced behavioral sen- 
